Staff, students and visitors are encouraged to consult the following (and current) policy and procedure documents should they have any questions in relation to human ethics.
Aboriginal and Torres Strait Islander research policy & guidelines
College of Medicine and Health Sciences
A researcher based at the Canberra Hospital who is also affiliated to The Australian National University will need to obtain ethics clearance both from the ACT Health Ethics Committee and from The Australian National University HREC. ACT Health HREC has agreements in place with the Australian National University (ANU) HREC to facilitate streamlined ethical approval processes for research projects that are defined as 'cross-institutional'.
If you are a researcher that requires ethics clearance from both HRECs, you should:
- Submit your protocol with ACT Health Ethics Committee
- Once the protocol has been cleared by ACT Health Ethics Committee, submit the ARIES expedited online application for an expedited review
If you are a researcher (from any college) conducting a clinical trial involving a drug or device, it will need to be assessed by the ACT Health Ethics Committee Clinical Trials Committee before being assessed by the ACT Health Ethics Committee and The Australian National University HREC. If you are conducting a clinical trial not involving a drug or device within the ACT Health system, it will need to be assessed by the ACT Health Ethics Committee. In both situations, once clearance is received by the ACT Health Ethics Committee for the clinical trial, please submit your application to The Australian National University HREC. If you are conducting a clinical trial that does not involve a drug or device and is not conducted within the ACT Health system, please submit your application direct to The Australian National University HREC.
See 'related links' at right side of page for further guidance on:
- the use of Data Safety Monitoring Boards (DSMBs)
- risk-based management and monitoring of clinical trials involving therapeutic goods, and
- reporting of serious breaches of Good Clinical Practice (GCP) or the protocol for trials involving therapeutic goods
Please note: If your clinical trial involves a DRUG OR DEVICE, you will need to provide a copy of your protocol (with attachments) to the Insurance Office. Please contact the Insurance Office on extension 54257 or email
for further information.